Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Follicular 12Lymphoma, B-Cell, Marginal Zone 11Lymphoma 9Lymphoma, Non-Hodgkin 8Lymphoma, Mantle-Cell 8Lymphoma, Large B-Cell, Diffuse 8Waldenstrom Macroglobulinemia 6Lymphoma, Large-Cell, Immunoblastic 4Burkitt Lymphoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia 2Graft vs Host Disease 1

Interventions

Cyclophosphamide 62Tacrolimus 52Methotrexate 39Mycophenolic Acid 36Busulfan 35fludarabine phosphate 34Cyclosporine 32Antilymphocyte Serum 32fludarabine 28Sirolimus 23Peripheral Blood Stem Cell Transplantation 22Melphalan 22Radiotherapy 21Methylprednisolone 20Whole-Body Irradiation 19Filgrastim 17thymoglobulin 14Thiotepa 10Stem Cell Transplantation 9Granulocyte Colony-Stimulating Factor 9Hematopoietic Stem Cell Transplantation 7Cord Blood Stem Cell Transplantation 7ruxolitinib 6Rituximab 6Etoposide 6Transplantation 5Therapeutics 5Prednisone 5Flow Cytometry 5Cytarabine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × ibritumomab tiuxetan × Other hematologic neoplasm × Clear all
NCT00577278 2024-02-16

A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan

City of Hope Medical Center

Phase 2 Completed
41 enrolled 10 charts
LymphoidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡